Rabbi Refuses to Leave Home Owned by Kesher Israel Synagogue
Rabbi Barry Freundel, who is accused of secretly videotaping women in a ritual bath, is reportedly refusing to leave a house owned by the Kesher Israel synagogue. The synagogue was adjacent to the bathing area where the illicit filming allegedly occurred. Kesher Israel filed a case against Freundel with the Beth Din of America, which is a rabbinic court […]
Next hearing for DC Rabbi Barry Freundel case set for Feb. 19
Rabbi Barry Freundel, formerly of the Kesher Israel Synagogue in Georgetown, was in Washington, DC Superior Court on Jan. 21 to answer for voyeurism charges. Prosecutors allege that Freundel secretly videotaped six women as they disrobed in preparation for a sacred bath known as a mikvah. During the short hearing, prosecutors were granted additional time […]
Managing Attorney interviewed on RT about Big Pharma industry
David Haynes, the managing attorney of The Cochran Firm, D.C., was recently a guest on The Big Picture to discuss the pharmaceutical industry's drug marketing and regulatory process. The Big Picture episode was hosted by prominent attorney Mike Papantonio and is carried in more than 50 million American homes, and more than 500 million homes worldwide. […]
DC Metro Accident and Smoke Inhalation
More than 80 people hospitalized after Metro cars at L’Enfant Plaza Metro stop fills with smoke One woman died, two others are in critical condition, and more than 80 other passengers were hospitalized after a Metro car became disabled and filled with smoke. The Yellow Line train was departing L’Enfant Plaza for Virginia when it […]
Benicar maker settles whistleblower lawsuit for $39 million
Daiichi Sankyo Inc. pays $39 million for allegedly violating anti-kickback law Japanese drug maker Daiichi Sankyo, Inc. has been ordered to pay $39 million to settle allegations it violated the Anti-Kickback Statute by paying physicians illicit fees to speak at lavish entertainment events that promoted blood pressure medications such as Benicar. Benicar is also sold as Azor, Tribenzor, Benicar HCT, […]
HHS proposes new requirements for drug studies
The Department of Health and Human Services (HHS) has published a proposal that, if adopted, would require drug makers to submit more information to regulators during clinical trials. HHS’ Notice of Proposed Rulemaking (NPRM) seeks to expand the statistical reporting that pharmaceutical companies must submit during clinical drug trials. The proposal was published in the […]
